VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
AAPG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AAPGAscentage Pharma Group International
$15.79$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAAPGQuarterly Financials

Ascentage Pharma Group International (AAPG) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Ascentage Pharma Group International (AAPG) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

AAPG Income Statement

Quarterly statement

AAPG Income Statement

Ascentage Pharma Group International (AAPG) annual income statement — 10-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17
Sales/Revenue298.88M334.13M233.7M156.9M823.75M79.28M142.7M104.86M104.86M14.95M12.96M6.22M6.22M7.26M7.26M5.11M1.7M6.05M275.25K
Revenue Growth %27.89%112.95%-71.63%97.9%477.26%-24.39%36.09%601.61%708.76%140.08%108.27%-14.21%-14.21%42.03%327.36%-15.59%516.9%--
Cost of Goods Sold48.01M68.69M21.65M14.03M15.06M12.39M18.15M11M11M739K2.59M983K983K1.05M1.05M-504.49K504.49K-276.84K276.84K
COGS % of Revenue16.06%20.56%9.26%8.94%1.83%15.63%12.72%10.49%10.49%4.94%19.97%15.79%15.79%14.44%14.44%-9.87%29.71%-4.57%100.58%
Gross Profit250.86M265.45M212.05M142.88M808.69M66.89M124.55M93.86M93.86M14.21M10.38M5.24M5.24M6.21M6.21M5.11M-363.27K6.33M-1.6K
Gross Margin %83.94%79.44%90.74%91.06%98.17%84.37%87.28%89.51%89.51%95.06%80.03%84.21%84.21%85.56%85.56%100%-21.39%104.57%-0.58%
Gross Profit Growth %18.3%85.79%-73.78%113.59%549.3%-28.73%32.7%560.68%804.55%171%97.94%-15.57%-15.57%21.52%1809.07%-19.28%-22661.09%--
Operating Expenses994.82M906.3M766.03M709.66M620.7M598.96M465.12M518.76M518.76M447.21M447.21M337.21M337.21M297.55M297.55M215.65M6.84M134.53M2.47M
OpEx % of Revenue332.85%271.24%327.79%452.29%75.35%755.46%325.94%494.74%494.74%2992.36%3449.35%5417.07%5417.07%4100.48%4100.48%4220.88%402.8%2222.55%897.47%
Selling, General & Admin316.01M318.79M237.47M206.5M176.63M201.8M174.66M164.01M164.01M95.63M95.63M32.03M32.03M49.43M49.43M42.53M1.58M12.62M787.26K
SG&A % of Revenue105.73%95.41%101.61%131.61%21.44%254.53%122.4%156.41%156.41%639.88%737.61%514.52%514.52%681.13%681.13%832.53%92.89%208.46%286.02%
Research & Development678.8M587.52M528.56M503.17M444.08M397.16M309.81M371.55M371.55M383.25M383.25M282.29M282.29M231.94M231.94M244.3M5.26M117.13M1.68M
R&D % of Revenue227.12%175.83%226.17%320.68%53.91%500.93%217.11%354.35%354.35%2564.37%2956%4534.71%4534.71%3196.33%3196.33%4781.81%309.9%1935.19%611.45%
Other Operating Expenses0000-2K0-1000K-1000K-1000K-1000K-1000K1000K1000K1000K1000K-1000K01000K0
Operating Income-743.95M-640.85M-553.98M-566.79M187.98M-532.07M-340.57M-424.9M-424.9M-434.92M-434.92M-331.97M-331.97M-291.34M-291.34M-338.24M-7.2M-128.2M-2.47M
Operating Margin %-248.91%-191.8%-237.05%-361.23%22.82%-671.09%-238.66%-405.23%-405.23%-2910.12%-3354.55%-5332.86%-5332.86%-4014.92%-4014.92%-6620.49%-424.19%-2117.98%-898.05%
Operating Income Growth %-34.29%-13.07%-394.7%-6.53%155.2%-25.22%19.85%2.3%2.3%-31.01%-31.01%-13.95%-13.95%13.87%-3944.88%-163.85%-191.39%--
EBITDA-701.08M-598.95M-514.02M-528.45M229.59M-492.67M-286.77M-420.34M-420.34M-432.72M-432.72M-329.98M-329.98M-289.43M-289.43M-319.56M-6.7M-115.97M-2.19M
EBITDA Margin %-234.57%-179.26%-219.95%-336.8%27.87%-621.4%-200.96%-400.88%-400.88%-2895.43%-3337.61%-5300.95%-5300.95%-3988.56%-3988.56%-6254.91%-394.48%-1916.02%-797.47%
EBITDA Growth %-36.39%-13.34%-323.89%-7.26%180.06%-17.21%31.78%2.86%2.86%-31.13%-31.13%-14.01%-14.01%9.43%-4220.96%-175.55%-205.16%--
D&A (Non-Cash Add-back)42.88M41.9M39.97M38.33M41.6M39.4M53.8M4.56M4.56M2.2M2.2M1.99M1.99M1.91M1.91M18.68M504.49K12.22M276.84K
EBIT-743.95M-640.85M-553.98M-566.79M187.98M-532.07M-304.74M-417.19M-417.19M-407.76M-407.76M-334.6M-334.6M-739.02M-739.02M-211.24M314.98K-60.56M-1.62M
Net Interest Income9.07M23.99M3.61M1.43M-28.04M-20.28M-43.37M-21.53M-21.53M-4.81M-4.81M-518.5K-518.5K4.32M4.32M-27.47M-2.39M-55.66M-1.98M
Interest Income35.59M49.78M3.61M1.43M1.3M3.64M32.41M4.86M4.86M3.55M3.55M2.61M2.61M6.45M6.45M7.06M0304K0
Interest Expense26.52M25.79M0028.04M20.28M75.78M26.39M26.39M8.37M8.37M3.13M3.13M2.14M2.14M34.53M2.39M55.96M1.98M
Other Income/Expense-50.55M2.14M-31.33M8.64M-25.09M-1.19M-59.04M-18.68M-18.68M18.79M7.31M-5.75M-5.75M-449.82M-449.82M-20.13M011.68M-1.13M
Pretax Income-794.51M-638.72M-585.31M-558.15M162.9M-533.26M-399.6M-443.59M-443.59M-416.12M-374.38M-337.72M-337.72M-741.16M-741.16M-358.37M-2.07M-116.52M-3.6M
Pretax Margin %-265.83%-191.16%-250.46%-355.73%19.77%-672.59%-280.03%-423.05%-423.05%-2784.37%-2887.59%-5425.29%-5425.29%-10213.71%-10213.71%-7014.44%-122.09%-1925.04%-1307.28%
Income Tax13.47M1.4M5.51M10.36M69K-9.9M2.75M-2.12M-2.12M-24.91M-24.91M1.08M1.08M-801K-801K801K-63.06K-1.54M-58.21K
Effective Tax Rate %-1.7%-0.22%-0.94%-1.86%0.04%1.86%-0.69%0.48%0.48%5.99%6.65%-0.32%-0.32%0.11%0.11%-0.22%3.04%1.32%1.62%
Net Income-807.68M-639.96M-590.77M-568.43M163M-523.29M-402.35M-441.46M-441.46M-391.21M-391.21M-338.8M-338.8M-740.36M-740.36M-343.3M-2.01M-114.97M-3.54M
Net Margin %-270.24%-191.53%-252.79%-362.28%19.79%-660.01%-281.96%-421.02%-421.02%-2617.68%-3017.45%-5442.62%-5442.62%-10202.67%-10202.67%-6719.45%-118.38%-1899.53%-1286.13%
Net Income Growth %-36.72%-12.58%-462.43%-8.63%140.51%-18.53%8.86%-12.84%-12.84%-15.47%-15.47%54.24%54.24%-115.66%-36732.23%-198.59%43.22%--
Net Income (Continuing)-807.98M-640.12M-590.82M-568.51M162.83M-523.36M-402.35M-441.46M-441.46M-391.21M-391.21M-338.8M-338.8M-740.36M-740.36M-343.3M-2.01M-114.97M-3.54M
Discontinued Operations0000000000000000000
Minority Interest9.45M9.76M9.91M9.97M10.04M10.21M10.29M000000000000
EPS (Diluted)-8.68-6.92-6.92-7.282.20-7.20-45.28-26.80-26.80-24.56-24.56-25.12-25.12-56.00-56.00-26.52-0.16-8.88-0.29
EPS Growth %-25.43%4.95%-414.55%-1.11%104.86%73.13%-68.96%-9.12%-9.12%2.23%2.23%55.14%55.14%-111.16%-34900%-198.65%44.83%--
EPS (Basic)-8.68-6.92-6.92-7.282.24-7.20-45.28-26.80-26.80-24.56-24.56-25.12-25.12-56.00-56.00-26.52-0.16-8.88-0.29
Diluted Shares Outstanding93.31M92.6M85.4M78.09M74.01M72.51M17.64M16.48M16.48M15.91M15.91M13.49M13.49M13.22M13.22M12.94M12.29M12.94M12.29M
Basic Shares Outstanding93.31M92.6M85.37M78.09M74.09M72.51M17.64M16.48M16.48M15.91M15.91M13.49M13.49M13.22M13.22M12.94M12.29M12.94M12.29M
Dividend Payout Ratio-------------------